Avertissement: Ce site agrège des données publiques officielles provenant de la FDA, ClinicalTrials.gov, PubMed et SEC EDGAR à titre de référence générale uniquement. Il ne constitue pas un avis médical, un diagnostic, une recommandation de traitement ni un conseil en investissement.

Essai clinique

Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.

NCT : NCT06075901 · ENROLLING_BY_INVITATION

ID NCTNCT06075901
StatutENROLLING_BY_INVITATION
Date de début2025-08-01
SponsorPaulista University (OTHER)
First posted
Last updated

Résumé succinct

Blood flow restriction (RFS) is a widely studied technique that combines low-intensity exercise with vascular occlusion, resulting in muscular benefits. However, its application is challenging due to methodological variations and equipment costs. Tissue Flossing (TF) appears as an affordable alternative, but lacks solid scientific evidence.

Source officielle

Voir sur ClinicalTrials.gov →

Données issues de l’API ClinicalTrials.gov. Pour connaître le statut le plus récent, consultez la fiche officielle.

↑